---

---

tags : Disease    entities : Astrazeneca plc   

save search

---

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| -5.48% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 1.1% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 9.6% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| -1.28% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 1.24% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $400.055 -0.18% 31K |

Health Technology

| -3.67% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 2.76% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $204.73 1.36% 100K |

Health Technology

| -10.88% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 16.66% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $271.635 -0.5% 120K |

Health Technology

| -6.01% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

---

Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -7.4% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 2.69% | O: 2.63% H: 0.8% C: 0.75%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -7.99% | O: 0.6% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -7.41% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 7.0% | O: 1.8% H: 0.14% C: -0.89%
disease vaccine respiratory global set market

---

Global NASH Market to Soar to $2.71 Billion by 2023, Driven by Rising Prevalence of Silent Liver Disease
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
IVA | $3.24 -1.52% -0.3% 0 |

Health Technology

| Email alert Add to watchlist
GALT | $3.29 -2.66% -2.74% 0 |

Health Technology

| Email alert Add to watchlist
GNFT | $3.49 1.31% -6.4% 0 |

Health Technology

| Email alert Add to watchlist
ICPT | $19.0 -0.05% 4M |

Health Technology

| Email alert Add to watchlist
IVEVF | $3.73 0% 1K |

n/a

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| Email alert Add to watchlist
MDGL | $204.65 -6.29% -6.78% 350 |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| Email alert Add to watchlist
GLMD | $0.4 10.68% 6.18% 590 |

Health Technology

| Email alert Add to watchlist
liver disease global nash market

---

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -0.73% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -8.4% | O: 0.52% H: 0.57% C: -0.56%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 7.33% | O: -0.5% H: 0.26% C: -0.69%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 31.1% | O: -1.47% H: 0.0% C: 0.0%
BMY | $46.72 -4.38% 2M |

Health Technology

| -16.88% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $168.67 0.52% 260K |

Health Technology

| 9.15% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -14.37% | O: -1.16% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 4.77% | O: 0.19% H: 0.03% C: -1.57%
AMGN | News | $271.635 -0.5% 120K |

Health Technology

| 0.57% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

---

Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published: 2023-08-25 (Crawled : 14:30) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -0.48% | O: -3.27% H: 3.65% C: 3.36%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 4.88% | O: 0.22% H: 0.6% C: 0.31%
AMGN | News | $271.635 -0.5% 120K |

Health Technology

| 6.39% | O: 0.19% H: 0.25% C: -0.28%
disease report cancer treatment research global technology

---

Acute Ischemic Stroke Therapeutics Market to grow by USD 1,524.49 million from 2022 to 2027|Rising prevalence of disease boosts the market - Technavio
Published: 2023-07-10 (Crawled : 19:00) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 0 |

Health Technology

| -7.02% | O: -0.15% H: 1.17% C: 1.12%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -8.67% | O: -0.12% H: 0.0% C: 0.0%
BIIB | $204.73 1.36% 100K |

Health Technology

| -28.27% | O: -0.56% H: 0.19% C: -0.06%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 9.22% | O: -0.28% H: 0.25% C: -0.23%
AMGN | News | $271.635 -0.5% 120K |

Health Technology

| 21.48% | O: -0.4% H: 0.78% C: 0.01%
disease stroke therapeutics market

---

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published: 2023-06-28 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 15.47% | O: 1.75% H: 0.06% C: 0.06%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -3.6% | O: 1.06% H: 0.72% C: 0.72%
ALPMY | News | $9.47 400K |

Manufacturing

| -37.57% | O: -1.98% H: 0.0% C: -0.47%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| -0.09% | O: 0.17% H: 0.85% C: 0.76%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 15.0% | O: -1.21% H: 1.17% C: 0.91%
ABT | News | $106.76 -0.12% 150K |

Health Technology

| -0.67% | O: -0.54% H: 0.78% C: 0.59%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -12.09% | O: -1.86% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 0.34% | O: -0.83% H: 0.89% C: 0.68%
lung disease report treatment global growth market

---

Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
Published: 2023-03-07 (Crawled : 15:00) - biospace.com/
PSNL | $1.3 -5.8% -6.15% 1 |

Health Technology

| -55.17% | O: 1.03% H: 7.76% C: 3.07%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 10.29% | O: 0.9% H: 0.28% C: -1.3%
research disease molecular

---

The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published: 2023-01-13 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -5.39% | O: -0.13% H: 0.76% C: 0.76%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -2.39% | O: 2.77% H: 0.63% C: 0.63%
TAK | News | $13.23 -1.12% 0.23% 690 |

Health Technology

| -15.95% | O: 0.13% H: 2.35% C: 2.16%
PFE | News 4 | $26.27 -0.19% -0.38% 130K |

Health Technology

| -44.94% | O: -0.44% H: 1.39% C: 0.74%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 8.6% | O: 0.15% H: 0.65% C: 0.4%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -14.86% | O: -0.47% H: 0.47% C: 0.14%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 109.46% | O: 0.13% H: 1.04% C: 0.57%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -1.9% | O: 1.89% H: 0.0% C: 0.0%
BMRN | $91.2 -0.93% -0.89% 550 |

Health Technology

| -18.88% | O: -1.16% H: 2.27% C: 0.42%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 1.6% | O: 1.27% H: 0.78% C: 0.15%
treatment disease expected

---

Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -2.34% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 0.18% | O: 1.08% H: 0.0% C: -0.25%
PFE | News 4 | $26.27 -0.19% -0.38% 130K |

Health Technology

| -48.82% | O: -0.08% H: 0.21% C: -0.1%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 7.37% | O: -0.01% H: 0.08% C: -0.95%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -16.57% | O: -0.04% H: 0.16% C: -0.47%
BMY | $46.72 -4.38% 2M |

Health Technology

| -32.23% | O: 0.04% H: 0.21% C: -0.25%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -2.28% | O: -0.39% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 2.5K |

Health Technology

| -21.32% | O: 0.08% H: 0.66% C: 0.61%
EXEL | $23.515 -0.82% 100K |

Health Technology

| 51.4% | O: -0.32% H: 2.91% C: 2.75%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 4.55% | O: -0.46% H: 0.38% C: 0.01%
global disease report therapeutics cancer market

---

Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-07 (Crawled : 16:00) - prnewswire.com
RBGPF | News | $53.94 3.53% 6.46% 0 |

Consumer Non-Durables

| -23.78% | O: 0.06% H: 3.15% C: 0.15%
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 5.31% | O: 0.74% H: 0.0% C: -6.74%
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -3.17% | O: 1.62% H: 0.0% C: -4.28%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| -1.02% | O: -0.56% H: 0.61% C: 0.01%
RBGLY | News | $10.98 2.0% -2.05% 250 |

Manufacturing

| -24.72% | O: 0.51% H: 0.48% C: -0.14%
VTRS | News A | $11.585 0.3% 150K |

Health Technology

| 5.67% | O: 0.0% H: 0.55% C: -0.27%
ZTS | $150.63 -0.17% 420K |

Health Technology

| -1.42% | O: -0.06% H: 0.54% C: -1.77%
PRGO | $31.23 2.43% 0.0% 210 |

Health Technology

| -1.58% | O: -0.09% H: 0.47% C: -0.28%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 7.75% | O: -0.98% H: 0.24% C: -1.78%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 104.11% | O: 0.21% H: 1.6% C: 0.72%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 5.15% | O: 5.18% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 3.85% | O: 0.45% H: 0.64% C: -0.03%
covid-19 research global disease report impact distribution market

---

Sickle Cell Disease Treatment Global Market to Reach $4 Billion by 2027
Published: 2022-09-16 (Crawled : 21:00) - prnewswire.com
BMY | $46.72 -4.38% 2M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 3 |

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| Email alert Add to watchlist
treatment global disease market

---

Polycystic Kidney Disease Drugs Market Report by Technavio predicts USD 510.69 Mn growth -- Driven by the high prevalence of chronic kidney diseases
Published: 2022-09-09 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| 23.26% | O: 4.47% H: 0.0% C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 13.78% | O: 5.77% H: 0.0% C: -2.47%
XRTX | News | $2.98 1.1K |

Mining, Quarrying, and Oil and ...

| 109.42% | O: -0.72% H: 1.46% C: -3.65%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 21.03% | O: 1.59% H: 0.27% C: 0.06%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| 19.09% | O: 2.11% H: 0.0% C: 0.0%
RGLS | $2.22 -1.77% -1.35% 360 |

Health Technology

| 38.75% | O: 3.12% H: 3.03% C: 1.82%
GLPG | News | $28.77 -2.31% -2.33% 1.5K |

Health Technology

| -40.77% | O: 0.47% H: 0.0% C: -1.31%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 18.04% | O: 1.43% H: 0.0% C: -0.54%
disease report kidney growth market

---

Global Chronic Obstructive Pulmonary Disease Treatment Market to Surpass US$ 25,601.45 Million by 2030 - Coherent Market Insights
Published: 2022-09-08 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| 30.51% | O: 2.63% H: 0.0% C: -3.84%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 18.98% | O: 6.1% H: 0.13% C: -1.44%
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 44.0% | O: 0.0% H: 0.0% C: -1.42%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 21.51% | O: -0.75% H: 1.17% C: 1.16%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| 29.76% | O: -1.84% H: 2.04% C: 1.94%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 19.02% | O: -0.47% H: 1.85% C: 1.31%
treatment global disease market

---

ENHERTU® Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician’s Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer
Published: 2022-08-15 (Crawled : 09:00) - biospace.com/
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 6.84% | O: 0.92% H: 0.22% C: -0.65%
enhertu treatment disease trial positive cancer her2- her2 metastatic breast cancer

---

U.S. Gastroesophageal Reflux Disease Devices Market Report 2022-2027: Key Players AstraZeneca, Pfizer, Procter & Gamble & Others Driving 15.47% Growth
Published: 2022-07-29 (Crawled : 20:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| Email alert Add to watchlist
TAK | News | $13.23 -1.12% 0.23% 690 |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| Email alert Add to watchlist
disease report growth market

---

Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 4.75% | O: -1.55% H: 4.43% C: 0.03%
PFE | News 4 | $26.27 -0.19% -0.38% 130K |

Health Technology

| -48.23% | O: 1.46% H: 1.45% C: 0.78%
NVO | News | $126.16 -1.93% -2.81% 100K |

Health Technology

| 12.83% | O: 0.72% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.32% 5.9K |

Health Technology

| 17.74% | O: 1.86% H: 1.05% C: 0.24%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -17.81% | O: 0.78% H: 0.94% C: 0.26%
CCXI | News | $51.99 -0.04% |

Health Technology

| 87.83% | O: -4.88% H: 1.04% C: -1.25%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 7.07% | O: -0.36% H: 1.22% C: 0.38%
disease therapy growth

---

Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| -27.82% | O: 0.0% H: 0.86% C: 0.84%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 7.76% | O: 4.83% H: 0.0% C: -5.0%
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| -16.42% | O: -0.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| -4.56% | O: 0.37% H: 3.03% C: 2.98%
LLY | News | $732.2 -1.81% -0.71% 8K |

Health Technology

| 139.05% | O: -3.62% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 12.09% | O: 0.54% H: 2.78% C: 2.69%
life disease

---

Gastrointestinal Diseases Therapeutics Market to record USD 22.82 Bn growth | Evolving Opportunities with Abbott Laboratories and AbbVie Inc. | Technavio
Published: 2022-04-15 (Crawled : 11:00) - prnewswire.com
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% 0.91% 11K |

Health Technology

| Email alert Add to watchlist
BHC | $8.465 -1.11% 93K |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -3.77% -14.18% 0 |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% 0.11% 67K |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| Email alert Add to watchlist
ABT | News | $106.76 -0.12% 150K |

Health Technology

| Email alert Add to watchlist
ABBV | News | $168.67 0.52% 260K |

Health Technology

| Email alert Add to watchlist
gastrointestinal therapeutics growth market disease

---

New Drug Delivery Systems Market 2022-2026 | Rising Prevalence Of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-02 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0 |

Health Technology

| -10.22% | O: -6.92% H: 1.86% C: 1.86%
AZNCF | News | $135.35 -3.53% -4.19% 0 |

Health Technology

| 8.35% | O: -5.26% H: 0.0% C: 0.0%
MDT | $80.38 -1.12% -0.03% 0 |

Health Technology

| -23.53% | O: 1.86% H: 0.0% C: 0.0%
BAX | $40.93 -0.22% 0.0% 3 |

Health Technology

| -51.98% | O: 0.28% H: 0.54% C: -0.33%
ABT | News | $106.76 -0.12% 150K |

Health Technology

| -11.19% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K |

Health Technology

| -5.88% | O: 0.18% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K |

Health Technology

| 15.06% | O: -2.63% H: 0.9% C: -0.3%
AMGN | News | $271.635 -0.5% 120K |

Health Technology

| 20.97% | O: 2.3% H: 0.0% C: 0.0%
new drug drug liver system disease growth drug delivery

---

Gainers vs Losers

50%

50%

Top 10 Gainers

CSSE 4 | $0.299 96.32% 7M |

Consumer Services

BRFH 4 | $1.99 80.91% 13M |

Manufacturing

BOF | $1.915 63.68% 620K |

AMST | $3.13 56.5% 500K |

Technology Services

ACON | $0.3595 24.83% 3.5M |

n/a

CDTX | News | $14.57 18.55% 330K |

Health Technology

ULBI M | $10.12 15.92% 120K |

Producer Manufacturing

LRHC | $1.79 11.88% 3K |

n/a

AIXI | $1.34 8.94% 42K |

n/a

TRU | $74.475 8.44% 100K |

Technology Services

---

Your saved searches

---